<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00743522</url>
  </required_header>
  <id_info>
    <org_study_id>448</org_study_id>
    <nct_id>NCT00743522</nct_id>
  </id_info>
  <brief_title>Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication</brief_title>
  <acronym>PROVIDE</acronym>
  <official_title>Programming Implantable Cardioverter Defibrillators (ICDs) in Patients With Primary Prevention Indication to Prolong Time to First Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although shock therapy is effective in terminating ventricular tachycardia (VT), it can be
      painful to the patient and repetitive shocks can decrease a patient's quality of life.
      Previous studies have suggested that one or more sets of aggressive device parameter settings
      may reduce the total number of shocks in primary prevention patients. In addition to shock
      therapies, antitachycardia pacing (ATP) is also available in ICDs to treat VT. The PROVIDE
      trial aims to prospectively study the effect of high detection rates, prolonged detection
      intervals, aggressive SVT discriminators, and extensive ATP therapy in prolonging the time to
      first shock in primary prevention patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint of this study is the rate of first shock</measure>
    <time_frame>Average follow-up period is 530 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The primary safety endpoint of this study is the rate of arrhythmic syncope</measure>
    <time_frame>Average follow-up period is 530 days</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1670</enrollment>
  <condition>Shock</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>PROVE Trial settings</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <description>Pre-selected settings</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICD/ CRT-D</intervention_name>
    <description>Cardiac device</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with approved ICD/CRT-D indications
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary Prevention indication for ICD/ CRT-D

        Exclusion Criteria:

          -  No prior documented history of spontaneous VT/VF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Saeed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hall-Garcia Cardiology Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hall-Garcia Cardiology Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C. Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol. 2014 Jan;25(1):52-9. doi: 10.1111/jce.12273. Epub 2013 Sep 24.</citation>
    <PMID>24112717</PMID>
  </results_reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2008</study_first_submitted>
  <study_first_submitted_qc>August 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2008</study_first_posted>
  <last_update_submitted>June 4, 2015</last_update_submitted>
  <last_update_submitted_qc>June 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reducing shocks</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

